When you need to map vaccine R&D around outbreak-prone pathogens, CEPI is less a patient-facing health site than a coalition website for understanding where preparedness funding, partnerships, and platform science are moving. It is useful for scanning work linked to pathogens such as Lassa fever, Nipah, MERS, Mpox, chikungunya, Ebola, and broader Disease X planning when the real question is who is helping push candidate vaccines toward readiness and access.
The site is public to browse and does not ask for patient information just to review its material, which suits early research and partner screening. Credibility is high because the content comes from a major epidemic-preparedness coalition, but the care boundary is clear: this is not bedside guidance, diagnosis support, or local outbreak reporting. Use it to assess vaccine strategy, access commitments, and preparedness initiatives, then verify any clinical or regulatory decision with WHO, regulators, and national public health sources.
